Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.71916 | 30 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.68857 | 30 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.69214 | 30 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.63223 | 30 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.61681 | 29 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.74754 | 30 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.70923 | 29 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.664 | 30 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.65048 | 30 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.67457 | 30 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.67294 | 30 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.66199 | 30 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.68074 | 30 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.67984 | 30 |